Navigating Ramadan with Diabetes

Navigating Ramadan with Diabetes

How can healthcare providers best guide Muslims living with diabetes to safely observe fasting during Ramadan?

Our host, Dr. Ronald Goldenberg, takes a deeper look into this topic with Dr. Ally Prebtani, a Professor of Medicine in the Department of Internal Medicine, Endocrinology & Metabolism at McMaster University.

This episode discusses the month of Ramadan, where a significant number of Muslims fast from dawn until dusk. Observing the Ramadan fast is associated with challenges and risks for those in the Muslim community living with diabetes. Our experts discuss risk stratification and how healthcare providers can be proactive in preparing those who choose to fast. They discuss practical tips to help people with diabetes safely navigate fasting during this holy month and emphasize the importance of understanding each person – who they are they, what treatments they are on, and how their diabetes care can be individualized.

Don’t miss the conversation!

The views and opinions expressed in this episode are those of the speakers and do not necessarily reflect the views or positions of any entities they represent.

Declaration of conflict of interest:

Dr. Goldenberg:

  • Direct financial relationship including receipt of honoraria: Abbott, Agora, Amgen, Antibody, AstraZeneca, Bayer, Boehringer Ingelheim, CCRN, CMSKTRG, Eli Lilly, EOCI, HIT Global, HLS, Inceptus, Janssen, LiV, Master Clinician Alliance, MD Briefcase, Merck, Mylan, Novo Nordisk, Sanofi, Script Medical, Servier, STA, Takeda, Toronto Knowledge Translation Working Group, Unik, Valeant. Membership on advisory boards or speaker’s bureau: Abbott, AstraZeneca, Bayer, Boehringer Ingelheim, Eli Lilly, HLS, Janssen, Merck, Novo Nordisk, Sanofi. Funded grants, research or clinical trials: Amgen, AstraZeneca, Boehringer Ingelheim, Eli Lilly, Janssen, Merck, Novo Nordisk, Sanofi.

Dr. Prebtani:

  • Direct financial relationship including receipt of honoraria: Eli Lilly, Astra Zeneca, BI, Abbott, Novo Nordisk, Sanofi. Funded grants, research or clinical trials: Hypertension Canada, Diabetes Canada.

Denne episoden er hentet fra en åpen RSS-feed og er ikke publisert av Podme. Den kan derfor inneholde annonser.

Episoder(26)

Exploring Second-Generation Basal Insulin Analogues 

Exploring Second-Generation Basal Insulin Analogues 

Do second-generation basal insulin analogues really offer any advantages over their first-generation counterparts?  Our host, Dr. Ronald Goldenberg, takes a deeper look into this topic with Dr. Alice ...

15 Nov 202213min

Navigating the Diabetes Canada Algorithm for Pharmacologic Glycemic Management of Type 2 Diabetes

Navigating the Diabetes Canada Algorithm for Pharmacologic Glycemic Management of Type 2 Diabetes

Diabetes Canada updated their recommendations for the pharmacologic glycemic management of type 2 diabetes in adults in 2020, but how can clinicians interpret and implement these guidelines in their e...

15 Nov 202228min

Managing Diabetes in Pregnancy  

Managing Diabetes in Pregnancy  

How do we approach diabetes management during pregnancy?Our host, Dr. Ronald Goldenberg, takes a deeper look into this topic with Dr. Denice Feig, an Endocrinologist, diabetes researcher, and champion...

1 Nov 202210min

Examining Diabetes and Renal Impairment 

Examining Diabetes and Renal Impairment 

Did you know that people with type 2 diabetes having chronic kidney disease are at an increased risk of hypoglycemia?Our host, Dr. Ronald Goldenberg, takes a deeper look into this topic with Dr. Alice...

15 Okt 202210min

Exploring Diabetes and Mental Health Issues

Exploring Diabetes and Mental Health Issues

Living with a chronic disease can take a toll on one’s mental health, so how can healthcare providers best support those living with diabetes?Our host, Dr. Ronald Goldenberg, takes a deeper look into ...

15 Okt 202219min

Recent Evidence for Fixed-Ratio Combinations of Basal Insulin and GLP-1 RA vs. Basal-Bolus Insulin in T2D: Updates from ADA 2022

Recent Evidence for Fixed-Ratio Combinations of Basal Insulin and GLP-1 RA vs. Basal-Bolus Insulin in T2D: Updates from ADA 2022

Fixed-ratio combinations of basal insulin and glucagon-like peptide-1 receptor agonist (GLP-1 RA) have demonstrated maintenance of HbA1c efficacy, less hypoglycemia, and weight loss compared to basal-...

1 Okt 202214min

Practical Tips to Interpreting Continuous Glucose Monitoring Metrics

Practical Tips to Interpreting Continuous Glucose Monitoring Metrics

With newer technologies being used to monitor blood glucose levels, how can we use data from continuous glucose monitoring (CGM) to inform the day-to-day management of diabetes?Our host, Dr. Ronald Go...

1 Okt 202221min

Populært innen Vitenskap

fastlegen
tingenes-tilstand
liberal-halvtime
jss
rss-zahid-ali-hjelper-deg
sinnsyn
forskningno
villmarksliv
rekommandert
rss-overskuddsliv
rss-paradigmepodden
vett-og-vitenskap-med-gaute-einevoll
nordnorsk-historie
tidlose-historier
dekodet-2
rss-inn-til-kjernen-med-sunniva-rose
fjellsportpodden
kvinnehelsepodden
diagnose
rss-nysgjerrige-norge